Tonix Pharmaceuticals Holding company info

What does Tonix Pharmaceuticals Holding do?
Tonix Pharmaceuticals (NASDAQ:TNXP) is a research-driven biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines to improve the lives of patients suffering from central nervous system (CNS) disorders, immunology, rare diseases, and infectious diseases. Dedicated to addressing unmet medical needs, Tonix Pharmaceuticals is actively engaged in developing a diverse portfolio of potential therapeutic solutions. Their projects range from preclinical to phase 3 clinical trials, with objectives to provide groundbreaking treatments for conditions lacking effective medications. The company's mission is to advance healthcare by delivering accessible, effective solutions to those in need, underscoring their commitment to innovation and patient care.
Tonix Pharmaceuticals Holding  company media
Company Snapshot

Is Tonix Pharmaceuticals Holding a public or private company?

key
Ownership
Public

How many people does Tonix Pharmaceuticals Holding employ?

people
Employees
103

What sector is Tonix Pharmaceuticals Holding in?

pie chart
Sector
Health Care

Where is the head office for Tonix Pharmaceuticals Holding ?

location pin
Head Office
New Jersey, United States

What year was Tonix Pharmaceuticals Holding founded?

founded flag
Year Founded
2007
What does Tonix Pharmaceuticals Holding specialise in?
/Biopharmaceutical Company /Clinical Stage /Central Nervous System /Analgesics Development /Immunology Research /Vaccine Development

What are the products and/or services of Tonix Pharmaceuticals Holding ?

Overview of Tonix Pharmaceuticals Holding offerings
TNX-102 SL - A sublingual tablet designed for the management of fibromyalgia and PTSD symptoms.
TNX-1800 - A live replicating vaccine being developed for the prevention of COVID-19.
TNX-1900 - A potential treatment for chronic migraine prevention, utilizing intranasal administration.
TNX-1300 - A biologic designed to treat cocaine intoxication by breaking down cocaine in the blood.

Who is in the executive team of Tonix Pharmaceuticals Holding ?

Tonix Pharmaceuticals Holding leadership team
  • Dr. Seth  Lederman M.D.
    Dr. Seth Lederman M.D.
    Co-Founder, President, CEO & Chairman
  • Mr. Bradley  Saenger CPA
    Mr. Bradley Saenger CPA
    CFO & Treasurer
  • Mrs. Jessica Edgar Morris
    Mrs. Jessica Edgar Morris
    Chief Operating Officer
  • Dr. Gregory M. Sullivan M.D.
    Dr. Gregory M. Sullivan M.D.
    Chief Medical Officer & Secretary
  • Dr. Herbert W. Harris M.D., Ph.D.
    Dr. Herbert W. Harris M.D., Ph.D.
    Executive Vice President of Translational Medicine
  • Dr. Bruce L. Daugherty M.B.A., Ph.D.
    Dr. Bruce L. Daugherty M.B.A., Ph.D.
    Executive Vice President of Research
  • Ms. Siobhan  Fogarty B.Sc., M.Sc.
    Ms. Siobhan Fogarty B.Sc., M.Sc.
    Executive Vice President of Product Development
  • Dr. Darryl  Rideout Ph.D.
    Dr. Darryl Rideout Ph.D.
    Executive Vice President of Experimental Chemistry